Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Ended earlyNCT02874430What this trial is testingMetformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine CancerWho this might be right forBreast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Early research (Phase 1)Looking for participantsNCT05542407What this trial is testingONC201 and Atezolizumab in Obesity-Driven Endometrial CancerWho this might be right forEndometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00003127What this trial is testingS9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial CancerWho this might be right forEndometrial Cancer SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116What this trial is testingEvaluate Lucitanib in Combination With Nivolumab in Patients With a Solid TumorWho this might be right forAdvanced Solid TumorGynecologic Cancer Clovis Oncology, Inc. 227
Large-scale testing (Phase 3)Looking for participantsNCT05256225What this trial is testingTesting the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaWho this might be right forEndometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more National Cancer Institute (NCI) 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318What this trial is testingTR115 in ARID1A-Mutated Advanced Solid TumorsWho this might be right forOvarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more Tarapeutics Science Inc. 50
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Study completedNCT00392769What this trial is testingCetuximab in Patients With Progressive or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Testing effectiveness (Phase 2)Study completedNCT03189446What this trial is testingVaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial CancerWho this might be right forEndometrial CancerPapillary SerousClear Cell Endometrial Cancer University of Oklahoma 39
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Large-scale testing (Phase 3)Study completedNCT00006027What this trial is testingComparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerWho this might be right forEndometrial Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289What this trial is testingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more Rahul Aggarwal 83
Large-scale testing (Phase 3)Study completedNCT00002493What this trial is testingRadiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerPsychosocial Effects of Cancer and Its Treatment Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT02059265What this trial is testingDasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60